(in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
---|---|---|---|---|
Current assets | ||||
Cash | $295.6 | $1963.14 | $402.41 | $302.69 |
Short term investments | ||||
Net receivables | $2198.78 | $2363.7 | $2405.89 | $2353.58 |
Inventory | $367.61 | $578.43 | $593.17 | $609.59 |
Total current assets | $3167.42 | $5220.03 | $3725.88 | $3596.56 |
Long term investments | ||||
Property, plant & equipment | $2088.44 | $2720.66 | $2682.25 | $2661.52 |
Goodwill & intangible assets | $6485.48 | $7622.61 | $7676.31 | $7673.79 |
Total noncurrent assets | $9252.03 | $11651.21 | $11671.62 | $11859.52 |
Total investments | ||||
Total assets | $12419.45 | $16871.24 | $15397.5 | $15456.08 |
Current liabilities | ||||
Accounts payable | $1096.19 | $1406.36 | $1048.61 | $1137.91 |
Deferred revenue | ||||
Short long term debt | $91.69 | $1668.15 | $180.6 | $179.57 |
Total current liabilities | $2489.41 | $5029.97 | $2875.96 | $2968.08 |
Long term debt | $6174.64 | $6958.53 | $7840.12 | $8216.64 |
Total noncurrent liabilities | $7083.4 | $8128.56 | $8970.27 | $9304.73 |
Total debt | $6266.33 | $8626.67 | $8020.72 | $8396.21 |
Total liabilities | $9572.82 | $13158.52 | $11846.23 | $12272.81 |
Shareholders' equity | ||||
Retained earnings | $79.3 | $964.16 | $787.44 | $477.63 |
Other shareholder equity | -$89.01 | -$98.24 | -$66.11 | -$95.62 |
Total shareholder equity | $2846.63 | $3712.72 | $3551.27 | $3183.27 |
(in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
---|---|---|---|---|
Current assets | ||||
Cash | $1963.14 | $329.45 | $532.59 | $2509.19 |
Short term investments | ||||
Net receivables | $2363.7 | $2147.96 | $1748.6 | $1431.21 |
Inventory | $578.43 | $552.39 | $412.68 | $436.47 |
Total current assets | $5220.03 | $3291.99 | $2898.86 | $4675.81 |
Long term investments | $262.61 | |||
Property, plant & equipment | $2720.66 | $2624.19 | $2626.25 | $2602.3 |
Goodwill & intangible assets | $7622.61 | $7628.85 | $7515.92 | $7276.47 |
Total noncurrent assets | $11651.21 | $11790.45 | $11477.31 | $11036.87 |
Total investments | ||||
Total assets | $16871.24 | $15082.44 | $14376.16 | $15712.68 |
Current liabilities | ||||
Accounts payable | $1406.36 | $1322.94 | $919.09 | $663.46 |
Deferred revenue | ||||
Short long term debt | $1668.15 | $133.91 | $126.13 | $171.72 |
Total current liabilities | $5029.97 | $3285.89 | $2857.43 | $2347.46 |
Long term debt | $6958.53 | $7651.48 | $7707.8 | $9520.17 |
Total noncurrent liabilities | $8128.56 | $8766.91 | $8795.86 | $10629.24 |
Total debt | $8626.67 | $7785.39 | $7833.93 | $9691.9 |
Total liabilities | $13158.52 | $12052.8 | $11653.29 | $12976.7 |
Shareholders' equity | ||||
Retained earnings | $964.16 | $406.78 | $327.56 | $532.38 |
Other shareholder equity | -$98.24 | -$111.57 | -$208.01 | -$307.26 |
Total shareholder equity | $3712.72 | $3029.64 | $2722.87 | $2735.99 |
(in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $4407.77 | $4901.56 | $4749.21 | $4602.09 |
Cost of revenue | $4045.08 | $4381.59 | $4314.71 | $4179.41 |
Gross Profit | $362.69 | $519.97 | $434.5 | $422.67 |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $90.19 | $104.49 | $95.59 | $103.9 |
Total operating expenses | $195.74 | $242.06 | $231.12 | $240.69 |
Operating income | $166.95 | $277.92 | $203.38 | $181.98 |
Income from continuing operations | ||||
EBIT | $166.97 | $329.74 | $579.28 | $182.14 |
Income tax expense | $23.87 | $12.83 | $128.05 | $12.08 |
Interest expense | $114.56 | $111.47 | $112.75 | $114.02 |
Net income | ||||
Net income | $28.54 | $205.43 | $338.48 | $56.04 |
Income (for common shares) | $28.54 | $205.43 | $338.48 | $56.04 |
(in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $18853.86 | $16326.62 | $12095.97 | $12829.56 |
Cost of revenue | $17037.8 | $14767.57 | $11007.08 | $11993.67 |
Gross Profit | $1816.06 | $1559.05 | $1088.88 | $835.89 |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $406.77 | $398.36 | $346.75 | $307.02 |
Total operating expenses | $953.13 | $930.69 | $897.44 | $1100.81 |
Operating income | $862.93 | $628.37 | $191.44 | -$264.92 |
Income from continuing operations | ||||
EBIT | $1291.31 | $628.67 | $269.9 | -$265.01 |
Income tax expense | $177.61 | $61.46 | -$40.63 | -$186.28 |
Interest expense | $439.58 | $372.73 | $401.37 | $382.8 |
Net income | ||||
Net income | $674.11 | $194.48 | -$90.83 | -$461.53 |
Income (for common shares) | $674.11 | $194.48 | -$90.83 | -$461.53 |
(in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
---|---|---|---|---|
Net income | $28.54 | $205.43 | $338.48 | $56.04 |
Operating activities | ||||
Depreciation | $105.54 | $137.57 | $135.52 | $136.79 |
Business acquisitions & disposals | -$83.32 | -$0.69 | -$18.32 | -$27.68 |
Stock-based compensation | $13.65 | $21.32 | $20.54 | $21.03 |
Total cash flows from operations | -$657.08 | $1036.52 | $22.63 | $314.48 |
Investing activities | ||||
Capital expenditures | -$111.2 | -$144.86 | -$103.01 | -$85.8 |
Investments | $51.87 | $629.18 | -$30 | |
Total cash flows from investing | -$197.97 | -$72.99 | $507.76 | -$141.73 |
Financing activities | ||||
Dividends paid | -$24.91 | -$28.72 | -$28.67 | -$28.66 |
Sale and purchase of stock | $4.5 | $3.26 | $9.66 | $4.44 |
Net borrowings | -$710.78 | $634.25 | -$400.42 | -$152.63 |
Total cash flows from financing | -$779 | $605.77 | -$429.45 | -$177.94 |
Effect of exchange rate | $5.33 | -$8.57 | -$1.22 | $2.83 |
Change in cash and equivalents | -$1628.71 | $1560.72 | $99.72 | -$2.36 |
(in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
---|---|---|---|---|
Net income | $674.11 | $194.48 | -$90.83 | -$461.53 |
Operating activities | ||||
Depreciation | $546.36 | $532.33 | $550.69 | $595.2 |
Business acquisitions & disposals | -$50.19 | -$340.02 | -$265.77 | -$20.94 |
Stock-based compensation | $86.94 | $95.49 | $71.05 | $30.34 |
Total cash flows from operations | $766.43 | $694.5 | $657.08 | $176.68 |
Investing activities | ||||
Capital expenditures | -$432.17 | -$364.75 | -$375.34 | -$365.7 |
Investments | $651.05 | -$142.22 | ||
Total cash flows from investing | $208.91 | -$831.29 | -$634.39 | -$361.12 |
Financing activities | ||||
Dividends paid | -$114.61 | -$113.12 | -$112.01 | -$110.89 |
Sale and purchase of stock | $46.97 | $49.32 | $41.59 | $83.48 |
Net borrowings | $751.75 | $52.65 | -$1875.18 | $2554.91 |
Total cash flows from financing | $653.65 | -$37.69 | -$2005.34 | $2437.52 |
Effect of exchange rate | $4.7 | -$28.66 | $6.05 | $9.46 |
Change in cash and equivalents | $1633.69 | -$203.14 | -$1976.6 | $2262.55 |
Aramark (NYSE:ARMK) Q2 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance
9 May 2024
|
Amalgamated Bank Has $4.62 Million Stake in Aramark (NYSE:ARMK)
ETF DAILY NEWS
8 May 2024
|
Aramark Earnings Surge 194% As It Nears A Fresh Buy Point
Investor's Business Daily
8 May 2024
|
Aramark (ARMK) Surpasses Q2 Earnings Estimates
Zacks via Yahoo Finance
7 May 2024
|
Aramark (NYSE:ARMK) Receives $33.04 Average Price Target from Brokerages
ETF DAILY NEWS
7 May 2024
|
Aramark (NYSE:ARMK) Pays A US$0.095 Dividend In Just Four Days
Simply Wall St. via Yahoo Finance
5 May 2024
|
A Look At The Intrinsic Value Of Aramark (NYSE:ARMK)
Simply Wall St. via Yahoo Finance
20 Mar 2024
|
Aramark (NYSE:ARMK) shareholders have earned a 2.2% CAGR over the last three years
Simply Wall St. via Yahoo Finance
29 Feb 2024
|
Aramark Stock In Buy Zone After Earnings Popped 173%
Investor's Business Daily
22 Feb 2024
|
Has Aramark (ARMK) Outpaced Other Consumer Staples Stocks This Year?
Zacks via Yahoo Finance
15 Feb 2024
|
Market cap | $8.73B |
---|---|
Enterprise value | $14.70B |
Shares outstanding | 262.29M |
Revenue | $18.66B |
---|---|
EBITDA | $1.77B |
EBIT | $1.26B |
Net Income | $628.49M |
Revenue Q/Q | -4.20% |
Revenue Y/Y | N/A |
P/E ratio | 13.89 |
---|---|
EV/Sales | 0.79 |
EV/EBITDA | 8.29 |
EV/EBIT | 11.69 |
P/S ratio | 0.47 |
P/B ratio | 2.97 |
Book/Share | 11.19 |
Cash/Share | 1.13 |
EPS | $2.40 |
---|---|
ROA | 4.18% |
ROE | 18.91% |
Debt/Equity | 3.54 |
---|---|
Net debt/EBITDA | 5.23 |
Current ratio | 1.27 |
Quick ratio | 1.12 |